In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses monitoring patients following their initial treatment.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

Over the years, cancer incidence has been steadily increasing in the country because of several factors like lifestyle ...

The bone marrow-on-a-chip allows researchers to simulate and study common side effects of medical treatments, such as ...

Helping people remain healthy and fit for as long as possible will be crucial as populations around the world get older.

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't kill it. But new research is promising.